-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Marker Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and change rate from Q1 2018 to Q1 2023.
- Marker Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2023 was $818K, a 42% increase year-over-year.
- Marker Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $2.79M, a 29.8% increase from 2021.
- Marker Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2021 was $2.15M, a 343% increase from 2020.
- Marker Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2020 was $486K, a 362% increase from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Change (%)
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Change (%)